|
|
|
Volumn 5, Issue 6, 2003, Pages 657-667
|
|
Technology evaluation: Bevacizumab, Genentech/Roche
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTHRACYCLINE DERIVATIVE;
BEVACIZUMAB;
CAPECITABINE;
CARBOPLATIN;
CISPLATIN;
CYTOKINE;
DOCETAXEL;
DOXORUBICIN;
ERLOTINIB;
FLUOROURACIL;
FOLINIC ACID;
GEMCITABINE;
IRINOTECAN;
MONOCLONAL ANTIBODY;
OMALIZUMAB;
OXALIPLATIN;
PACLITAXEL;
PLACEBO;
TAXANE DERIVATIVE;
TRASTUZUMAB;
VASCULOTROPIN;
VASCULOTROPIN ANTIBODY;
ABDOMINAL PAIN;
ANEMIA;
ANGIOGENESIS;
ARTICLE;
ASTHENIA;
BIOTECHNOLOGY;
BLEEDING DISORDER;
BODY WEIGHT DISORDER;
BRAIN HEMORRHAGE;
BREAST CANCER;
CHILL;
CLINICAL TRIAL;
COLORECTAL CANCER;
DEEP VEIN THROMBOSIS;
DIARRHEA;
DIGESTIVE SYSTEM PERFORATION;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DISPOSITION;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG ERUPTION;
DRUG FATALITY;
DRUG HALF LIFE;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
DRUG SYNTHESIS;
EPISTAXIS;
FATIGUE;
FEBRILE NEUTROPENIA;
FEVER;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL HEMORRHAGE;
HEADACHE;
HEMOPTYSIS;
HUMAN;
HYPERTENSION;
INFECTION;
LEUKOPENIA;
LUNG NON SMALL CELL CANCER;
MESENTERIC VEIN THROMBOSIS;
NAUSEA;
NEPHROTIC SYNDROME;
NEUTROPENIA;
NONHUMAN;
PROTEINURIA;
SOLID TUMOR;
STOMACH ULCER;
STOMATITIS;
STRUCTURE ACTIVITY RELATION;
THROMBOCYTOPENIA;
THROMBOEMBOLISM;
THROMBOSIS;
TUMOR BLEEDING;
WEIGHT REDUCTION;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
MICE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 0347719608
PISSN: 14648431
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (47)
|
|
References (0)
|
